American College of Cardiology (ACC)

The American College of Cardiology (ACC) is the primary U.S. medical society representing the interests of all cardiology subspecialities. The ACC is very active in setting guidelines for cardiac care, lobbying for supportive government policy and reimbursements, clinician education, managing several key cardiovascular registries and advocating for the transformation of cardiovascular care to improve heart health.

Key takeaways from ACC.25: Advances in cardiovascular science
Former American College of Cardiology president Hadley Wilson, MD, executive vice chair of Atrium Health Sanger Heart and Vascular Institute, explains his main takeaway messages from the ACC 2025 late-breaking trials.
New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS
Two separate studies at ACC.25 explored data from the EARLY TAVR trial. One analysis included stroke findings that surprised researchers.
Dapagliflozin improves outcomes for elderly TAVR patients with heart failure
The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.
Plant-based diets may help patients with diabetes, heart disease live longer
Researchers focused on data from nearly 78,000 adults with cardiometabolic disorders, sharing their findings at ACC.25 in Chicago.
So far, so good: TAVR comparable to open heart surgery after 5 years in low-risk patients
Michael J. Reardon, MD, shared the highly anticipated data with a large audience at ACC.25 in Chicago. Overall, he said, these five-year findings suggest TAVR with a supra-annular, self-expanding valve is a safe and effective alternative to SAVR.

healthcare value value-based care money dollar

American College of Cardiology’s HeartPAC temporarily pausing individual political contributions

The Jan. 6 riot at the U.S. Capitol and continued division between the country’s political parties appear to be at the center of the committee’s decision.

American College of Cardiology shares new treatment guidelines for HFrEF, emphasizing team-based approach

The document, published in the Journal of the American College of Cardiology, includes updated data and new treatment strategies.

To help ease COVID concerns, American College of Cardiology will offer continuous screening for conference attendees

In 2020, COVID-19 forced the ACC to cancel its entire annual meeting just weeks before it was scheduled to take place.

Same-day discharge after PCI? American College of Cardiology shares a new guidance

Knowing when same-day discharge is the right choice—and when it isn’t—can be especially challenging for cardiologists and their care teams.

American College of Cardiology shares new guidelines for treating patients with anticoagulant and antiplatelet therapy

The ACC is celebrating the holiday season with a new gift for cardiologists.

American College of Cardiology, American Heart Association share new recommendations for managing valvular heart disease

The new document, published in both the Journal of the American College of Cardiology and Circulation, highlights the significant progress researchers and clinicians have made in this area in recent years.

American College of Cardiology, American Heart Association update AFib performances measures

The Heart Rhythm Society also contributed to the guidance.

American Heart Association, American College of Cardiology share updated guidance on hypertrophic cardiomyopathy

The two groups emphasized the importance of shared decision-making and detailed when patients can consider competitive sports.

American College of Cardiology (ACC)

Key takeaways from ACC.25: Advances in cardiovascular science

New TAVR research explores adverse outcomes, disease progression in patients with asymptomatic severe AS

Dapagliflozin improves outcomes for elderly TAVR patients with heart failure

Plant-based diets may help patients with diabetes, heart disease live longer

So far, so good: TAVR comparable to open heart surgery after 5 years in low-risk patients